肠道菌群与银屑病关系的研究进展

doi:10.3760/cma.j.issn.0412-4030.2019.05.018

摘要/Abstract

摘要： 【摘要】银屑病是一种慢性炎症性复发性皮肤病，发病机制至今尚未完全清楚，目前认为免疫、遗传及环境因素在其发病中起重要作用。越来越多研究证明，肠道菌群失调与免疫疾病有关，尤其与炎症性肠病关系密切。而银屑病与炎症性肠病发病机制及临床表现上有众多相似之处，肠道微生物群变化也被证实与银屑病有关。本文就银屑病与肠道菌群失调之间的可能关联展开讨论。

关键词: 银屑病, 肠道菌群失调

Abstract: 【Abstract】 Psoriasis is a chronic recurrent inflammatory skin disease, and its pathogenesis is still unclear. At present, it is believed that immune, genetic and environmental factors play important roles in the occurrence of psoriasis. More and more studies have indicated that the imbalance of intestinal flora is associated with immune diseases, especially inflammatory bowel disease. The pathogenesis and clinical manifestations of psoriasis are similar to those of inflammatory bowel disease, and psoriasis is proved to be associated with changes in intestinal microbial flora. This review discusses the association between the imbalance of intestinal flora and psoriasis.

Key words: Psoriasis, Imbalance of intestinal flora

王丽玮罗玲玲崔盘根李岷. 肠道菌群与银屑病关系的研究进展[J]. 中华皮肤科杂志, 2019, 52(5): 357-360.

Wang Liwei, Luo Lingling, Cui Pan′gen, Li Min. Relationship between intestinal flora and psoriasis[J]. Chinese Journal of Dermatology, 2019, 52(5): 357-360.

参考文献 51

［1］	Costello ME, Ciccia F, Willner D, et al. Brief report: intestinal dysbiosis in ankylosing spondylitis［J］. Arthritis Rheumatol, 2015,67（3）:686⁃691. doi: 10.1002/art.38967.
［2］	Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system［J］. Nat Immunol, 2013,14（7）:676⁃684. doi: 10.1038/ni.2640.
［3］	Felix KM, Tahsin S, Wu HJ. Host⁃microbiota interplay in mediating immune disorders［J］. Ann N Y Acad Sci, 2018,1417（1）:57⁃70. doi: 10.1111/nyas.13508.
［4］	Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system［J］. Nat Rev Immunol, 2017,17（4）:219⁃232. doi: 10.1038/nri.2017.7.
［5］	de Oliveira GLV, Leite AZ, Higuchi BS, et al. Intestinal dysbiosis and probiotic applications in autoimmune diseases［J］. Immunology, 2017,152（1）:1⁃12. doi: 10.1111/imm.12765.
［6］	Delzenne NM, Cani PD, Everard A, et al. Gut microorganisms as promising targets for the management of type 2 diabetes［J］. Diabetologia, 2015,58（10）:2206⁃2217. doi: 10.1007/s00125⁃015⁃3712⁃7.
［7］	Neuman H, Koren O. The gut microbiota: a possible factor influencing systemic lupus erythematosus［J］. Curr Opin Rheumatol, 2017,29（4）:374⁃377. doi: 10.1097/BOR.000000000 0000395.
［8］	Maeda Y, Kumanogoh A, Takeda K. Altered composition of gut microbiota in rheumatoid arthritis patients［J］. Nihon Rinsho Meneki Gakkai Kaishi, 2016,39（1）:59⁃63. doi: 10.2177/jsci.39. 59.
［9］	Becker C, Neurath MF, Wirtz S. The intestinal microbiota in inflammatory bowel disease［J］. ILAR J, 2015,56（2）:192⁃204. doi: 10.1093/ilar/ilv030.
［10］	Zákostelská Z, Málková J, Klimešová K, et al. Intestinal microbiota promotes psoriasis⁃like skin inflammation by enhancing Th17 response［J/OL］. PLoS One, 2016,11（7）:e0159539. doi: 10.1371/journal.pone.0159539.
［11］	Christophers E. Psoriasis⁃⁃epidemiology and clinical spectrum［J］. Clin Exp Dermatol, 2001,26（4）:314⁃320.
［12］	Skov L, Baadsgaard O. Bacterial superantigens and inflammatory skin diseases［J］. Clin Exp Dermatol, 2000,25（1）:57⁃61.
［13］	Fry L, Baker BS. Triggering psoriasis: the role of infections and medications［J］. Clin Dermatol, 2007,25（6）:606⁃615. doi: 10. 1016/j.clindermatol.2007.08.015.
［14］	Williams JP, Meyers JA. Immune⁃mediated inflammatory disorders （I.M.I.D.s）: the economic and clinical costs［J］. Am J Manag Care, 2002,8（21 Suppl）:S664⁃S681.
［15］	Harlan WR, Meyer A, Fisher J. Inflammatory bowel disease: epidemiology, evaluation, treatment, and health maintenance［J］. N C Med J, 2016,77（3）:198⁃201. doi: 10.18043/ncm.77.3.198.
［16］	Dogra S, Mahajan R. Psoriasis: epidemiology, clinical features, co⁃morbidities, and clinical scoring［J］. Indian Dermatol Online J, 2016,7（6）:471⁃480. doi: 10.4103/2229⁃5178.193906.
［17］	Skroza N, Proietti I, Pampena R, et al. Correlations between psoriasis and inflammatory bowel diseases［J］. Biomed Res Int, 2013,2013:983902. doi: 10.1155/2013/983902.
［18］	Pietrzak D, Pietrzak A, Krasowska D, et al. Digestive system in psoriasis: an update［J］. Arch Dermatol Res, 2017,309（9）:679⁃693. doi: 10.1007/s00403⁃017⁃1775⁃7.
［19］	Vlachos C, Gaitanis G, Katsanos KH, et al. Psoriasis and inflammatory bowel disease: links and risks［J］. Psoriasis （Auckl）, 2016,6:73⁃92. doi: 10.2147/PTT.S85194.
［20］	McIlroy J, Ianiro G, Mukhopadhya I, et al. Review article: the gut microbiome in inflammatory bowel disease⁃avenues for microbial management［J］. Aliment Pharmacol Ther, 2018,47（1）:26⁃42. doi: 10.1111/apt.14384.
［21］	Rath HC, Herfarth HH, Ikeda JS, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA⁃B27/human beta2 microglobulin transgenic rats［J］. J Clin Invest, 1996,98（4）:945⁃953. doi: 10.1172/JCI 118878.
［22］	Reveille JD. Genetics of spondyloarthritis⁃⁃beyond the MHC［J］. Nat Rev Rheumatol, 2012,8（5）:296⁃304. doi: 10.1038/nrrheum. 2012.41.
［23］	Negi S, Singh H, Mukhopadhyay A. Gut bacterial peptides with autoimmunity potential as environmental trigger for late onset complex diseases: In⁃silico study［J/OL］. PLoS One, 2017,12（7）:e0180518. doi: 10.1371/journal.pone.0180518.
［24］	Luckey D, Gomez A, Murray J, et al. Bugs & us: the role of the gut in autoimmunity［J］. Indian J Med Res, 2013,138（5）:732⁃743.
［25］	Liu X, Zeng B, Zhang J, et al. Role of the gut microbiome in modulating arthritis progression in mice［J］. Sci Rep, 2016,6:30594. doi: 10.1038/srep30594.
［26］	Scarpa R, Manguso F, D′Arienzo A, et al. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms［J］. J Rheumatol, 2000,27（5）:1241⁃1246.
［27］	Stebbings S, Munro K, Simon MA, et al. Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis［J］. Rheumatology （Oxford）, 2002,41（12）:1395⁃1401.
［28］	Scher JU, Ubeda C, Artacho A, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease［J］. Arthritis Rheumatol, 2015,67（1）:128⁃139. doi: 10. 1002/art.38892.
［29］	Tan L, Zhao S, Zhu W, et al. The Akkermansia muciniphila is a gut microbiota signature in psoriasis［J］. Exp Dermatol, 2018,27（2）:144⁃149. doi: 10.1111/exd.13463.
［30］	Eppinga H, Sperna WCJ, Thio HB, et al. Similar depletion of protective Faecalibacterium prausnitzii in psoriasis and inflammatory bowel disease, but not in hidradenitis suppurativa［J］. J Crohns Colitis, 2016,10（9）:1067⁃1075. doi: 10.1093/ecco⁃jcc/jjw070.
［31］	Everard A, Belzer C, Geurts L, et al. Cross⁃talk between Akkermansia muciniphila and intestinal epithelium controls diet⁃induced obesity［J］. Proc Natl Acad Sci U S A, 2013,110（22）:9066⁃9071. doi: 10.1073/pnas.1219451110.
［32］	Png CW, Lindén SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria［J］. Am J Gastroenterol, 2010,105（11）:2420⁃2428. doi: 10.1038/ajg.2010.281.
［33］	Bos JD, de Rie MA, Teunissen MB, et al. Psoriasis: dysregulation of innate immunity［J］. Br J Dermatol, 2005,152（6）:1098⁃1107. doi: 10.1111/j.1365⁃2133.2005.06645.x.
［34］	Perez⁃Lopez A, Behnsen J, Nuccio SP, et al. Mucosal immunity to pathogenic intestinal bacteria［J］. Nat Rev Immunol, 2016,16（3）:135⁃148. doi: 10.1038/nri.2015.17.
［35］	Johansson ME, Phillipson M, Petersson J, et al. The inner of the two Muc2 mucin⁃dependent mucus layers in colon is devoid of bacteria［J］. Proc Natl Acad Sci U S A, 2008,105（39）:15064⁃15069. doi: 10.1073/pnas.0803124105.
［36］	Johansson ME, Gustafsson JK, Sjöberg KE, et al. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model［J/OL］. PLoS One, 2010,5（8）:e12238. doi: 10.1371/journal.pone.0012238.
［37］	Asquith MJ, Stauffer P, Davin S, et al. Perturbed mucosal immunity and dysbiosis accompany clinical disease in a rat model of spondyloarthritis［J］. Arthritis Rheumatol, 2016,68（9）:2151⁃2162. doi: 10.1002/art.39681.
［38］	Tervaniemi MH, Katayama S, Skoog T, et al. NOD⁃like receptor signaling and inflammasome⁃related pathways are highlighted in psoriatic epidermis［J］. Sci Rep, 2016,6:22745. doi: 10.1038/srep22745.
［39］	McGovern D, Powrie F. The IL23 axis plays a key role in the pathogenesis of IBD［J］. Gut, 2007,56（10）:1333⁃1336. doi: 10. 1136/gut.2006.115402.
［40］	Omenetti S, Pizarro TT. The Treg/Th17 Axis: a dynamic balance regulated by the gut microbiome［J］. Front Immunol, 2015,6:639. doi: 10.3389/fimmu.2015.00639.
［41］	Schnupf P, Gaboriau⁃Routhiau V, Sansonetti PJ, et al. Segmented filamentous bacteria, Th17 inducers and helpers in a hostile world［J］. Curr Opin Microbiol, 2017,35:100⁃109. doi: 10.1016/j.mib.2017.03.004.
［42］	Jacobs JP, Braun J. Immune and genetic gardening of the intestinal microbiome［J］. FEBS Lett, 2014,588（22）:4102⁃4111. doi: 10.1016/j.febslet.2014.02.052.
［43］	Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T⁃cell development by a commensal bacterium of the intestinal microbiota［J］. Proc Natl Acad Sci U S A, 2010,107（27）:12204⁃12209. doi: 10.1073/pnas.0909122107.
［44］	Hayashi A, Sato T, Kamada N, et al. A single strain of Clostridium butyricum induces intestinal IL⁃10⁃producing macrophages to suppress acute experimental colitis in mice［J］. Cell Host Microbe, 2013,13（6）:711⁃722. doi: 10.1016/j.chom. 2013.05.013.
［45］	Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species［J］. Science, 2011,331（6015）:337⁃341. doi: 10.1126/science.1198469.
［46］	David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome［J］. Nature, 2014,505（7484）:559⁃563. doi: 10.1038/nature12820.
［47］	Vasseur P, Serres L, Jégou JF, et al. High⁃fat diet⁃induced IL⁃17A exacerbates psoriasiform dermatitis in a mouse model of steatohepatitis［J］. Am J Pathol, 2016,186（9）:2292⁃2301. doi: 10.1016/j.ajpath.2016.05.012.
［48］	Higashi Y, Yamakuchi M, Fukushige T, et al. High⁃fat diet exacerbates imiquimod⁃induced psoriasis⁃like dermatitis in mice［J］. Exp Dermatol, 2018,27（2）:178⁃184. doi: 10.1111/exd.13484.
［49］	Mullish BH, Quraishi MN, Segal JP, et al. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology （BSG） and Healthcare Infection Society （HIS） guidelines［J］. Gut, 2018,67（11）:1920⁃1941. doi: 10.1136/gutjnl⁃2018⁃316818.
［50］	Paramsothy S, Paramsothy R, Rubin DT, et al. Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta⁃analysis［J］. J Crohns Colitis, 2017,11（10）:1180⁃1199. doi: 10.1093/ecco⁃jcc/jjx063.
［51］	Kragsnaes MS, Kjeldsen J, Horn HC, et al. Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6⁃month, double⁃blind, randomised, placebo⁃controlled trial［J］. BMJ Open, 2018,8（4）:e019231. doi: 10.1136/bmjopen⁃2017⁃019231.

[1]	陈怡雯苏婷苏忠兰. 银屑病与STAT3[J]. 中华皮肤科杂志, 2019, 52(7): 502-505.
[2]	苏蓓蓓甘泉甘才斌. 二甲双胍对银屑病样小鼠模型皮损炎症状态及磷酸化Stat3蛋白表达的影响[J]. 中华皮肤科杂志, 2019, 52(7): 475-480.
[3]	覃慧郑捷. 鞘氨醇1-磷酸盐受体拮抗剂（FTY720）抑制皮肤中分泌白细胞介素17的γδT细胞治疗银屑病的机制研究[J]. 中华皮肤科杂志, 2019, 52(6): 395-400.
[4]	胡煜陈敏顾恒. microRNA和lncRNA在银屑病中的研究进展[J]. 中华皮肤科杂志, 2019, 52(5): 350-353.
[5]	潘家旭周婧. 核因子κB信号通路在银屑病中的研究进展[J]. 中华皮肤科杂志, 2019, 52(5): 361-363.
[6]	曾菁莘田歆朱慧兰张锡宝林玲张丽丹刘炜钰罗权. 微小RNA-148a-3p在寻常型银屑病患者外周血CD4⁺ T淋巴细胞中的表达及临床意义[J]. 中华皮肤科杂志, 2019, 52(4): 231-235.
[7]	中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南（2018简版）[J]. 中华皮肤科杂志, 2019, 52(4): 223-230.
[8]	中国医师协会皮肤科医师分会规范化诊疗工作委员会中国医学装备协会皮肤病与皮肤美容专业委员会皮肤外科装备学组和皮肤光治疗学组. 窄谱中波紫外线家庭光疗临床应用专家共识[J]. 中华皮肤科杂志, 2019, 52(3): 156-161.
[9]	高祎濛晋红中. 精神神经因素在银屑病发病中的作用[J]. 中华皮肤科杂志, 2019, 52(3): 204-207.
[10]	关欣张春雷. 英夫利西单抗长疗程治疗中重度寻常性银屑病的疗效评价[J]. 中华皮肤科杂志, 2019, 52(2): 86-89.
[11]	彭琛陈文娟于宁高芸璐易雪梅丁杨峰. 银屑病皮肤及肠道微生态研究进展[J]. 中华皮肤科杂志, 2019, 52(2): 135-137.
[12]	王刚. 皮肤科生物制剂的主要不良反应及对策[J]. 中华皮肤科杂志, 2019, 52(2): 77-80.
[13]	胡煜栾超练霓郝志敏孙玉洁王焱顾恒陈敏. 银屑病患者血浆中前蛋白转化酶枯草溶菌素9的表达及对外周血CD4+ T细胞活化的影响[J]. 中华皮肤科杂志, 2019, 52(2): 90-93.
[14]	熊娟娟毕健平孙德祥李念鲁巧云. 甲真菌病和甲银屑病的皮肤镜特征分析[J]. 中华皮肤科杂志, 2019, 52(2): 106-110.
[15]	刘娜覃慧郑捷. 组织常驻记忆性T细胞与银屑病[J]. 中华皮肤科杂志, 2018, 51(8): 630-632.